Clinical Trials List
2015-11-01 - 2025-08-29
Phase III
Terminated5
ICD-10C34
Malignant neoplasm of bronchus and lung
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Trial Applicant
BRISTOL-MYERS SQUIBB (TAIWAN) LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- JENG-SEN TSENG Division of Thoracic Medicine
- 陳焜結 Division of Thoracic Medicine
- KUO-HSUAN HSU Division of Thoracic Medicine
- Gee-chen Chang Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chao-Hua Chiu Division of Thoracic Medicine
- 蕭慈慧 Division of Thoracic Medicine
- Yung-Hung Luo Division of Thoracic Medicine
- Hsu-ching Huang Division of Thoracic Medicine
- Heng-Sheng Chao Division of Thoracic Medicine
- 蔡俊明 Division of Thoracic Medicine
- Chi-Lu Chiang Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- JIN-YUAN SHIH Division of Thoracic Medicine
- 廖唯昱 Division of Thoracic Medicine
- 陳冠宇 Division of Thoracic Medicine
- Jih-Hsiang Lee Division of Thoracic Medicine
- James Chih-Hsin Yang Division of Thoracic Medicine
- CHAO-CHI HO CHAO-CHI HO Division of Thoracic Medicine
- 許嘉林 Division of Thoracic Medicine
- Chia-Chi Lin Division of Thoracic Medicine
- 林育麟 Division of Thoracic Medicine
- 楊景堯 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Audit
None
Co-Principal Investigator
- Chih-Cheng Chang Division of Thoracic Medicine
- Po-Hao Feng Division of Thoracic Medicine
- Tzu-Tao Chen Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Wen-Cheng Chang Division of Hematology & Oncology
- Chih-Hung Chen Division of Hematology & Oncology
- Chih-Liang Wang Division of Hematology & Oncology
- 李忠恕 Division of Hematology & Oncology
- 黃世豪 Division of Hematology & Oncology
- 謝任富 Division of Hematology & Oncology
- Chien-Ying Liu Division of Hematology & Oncology
- Shih-Hong Li Division of Hematology & Oncology
- Kuo-Chin Kao Division of Hematology & Oncology
- 林倡葦 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
2 Terminated
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
1980 participants